Summary of all studies containing PUBCHEM ID 6441886
| Project | Study | Study_title | Subject_type | Subject_species | Metabolite_name |
|---|---|---|---|---|---|
| PR000357 | ST000465 | Uniquely Tumor-Selective Englerin A Profoundly Alters Lipid Metabolism in Renal Cell Carcinoma inducing ER-Stress and an Acute Inflammatory Response | Human renal cancer cells | Homo sapiens | PC(16:0/22:6) [Data] |
| PR000451 | ST000617 | Validation of the application of targeted metabolomic appraoch in the diagnosis of CFS | Human | Homo sapiens | PC(16:0/22:6) [Data] |
| PR000627 | ST000903 | Pharmacometabolomic analysis of rat hippocampus and plasma in response to chronic stress and albiflorin treament | Animal | Rattus norvegicus | PC(16:0/22:6) [Data] |
| PR000776 | ST001157 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) | Mammal | Mus musculus | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR000776 | ST001158 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) | Mammal | Mus musculus | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR000840 | ST001253 | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Mammal | Mus musculus | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR000907 | ST002089 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Human | Homo sapiens | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR000967 | ST001411 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Human | Homo sapiens | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001048 | ST001639 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Human | Homo sapiens | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001048 | ST002088 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Human | Homo sapiens | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001121 | ST001749 | REACH Metabolomics Study | Human | Homo sapiens | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001129 | ST001775 | Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi | Mammal | Mus musculus | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001133 | ST001780 | Comparative analysis of metabolomic profiles in cerebrospinal fluid before and after endurance exercise | Human | Homo sapiens | PC(16:0/22:6) [Data] |
| PR001133 | ST001789 | Acute metabolomic changes of plasma in response to endurance exercise | Human | Homo sapiens | PC(16:0/22:6) [Data] |
| PR001159 | ST001835 | Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes | Human | Homo sapiens | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001180 | ST001869 | WNK463 Inhibition on Right Ventricular metabolomics | Mammal | Rattus norvegicus | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001180 | ST001870 | Effects of GP130 Antagonism on Right Ventricular Metabolism in Monocrotaline Rats | Mammal | Rattus norvegicus | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001282 | ST002019 | TIPs Metabolomics (blood) | Human | Homo sapiens | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001285 | ST002023 | A targeted metabolomics study for assessing rodent thyroid toxicity | Mammal | Rattus norvegicus | Glycerophospholipids__PC aa C38:6 [Data] |
| PR001299 | ST002054 | Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance | Cultured cells | Homo sapiens | PC 38:6 [Data] |
| PR001400 | ST002196 | Metabolic signature of idiopathic inflammatory myopathy | Human | Homo sapiens | PC aa C38:6 [Data] |
| PR001451 | ST002269 | Targeted plasma metabolomics in pediatric NAFLD patients | Human | Homo sapiens | PC(38:6) [Data] |
| PR001488 | ST002322 | Metabolomics study comparing SCAP KO and WT B cells | Cultured cells | Mus musculus | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001613 | ST002498 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Human | Homo sapiens | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001715 | ST002754 | Metabolomics analysis of maternal obesity model | Mammal | Mus musculus | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001756 | ST002809 | Role of cilia in mitochondrial function | Mammal | Mouse/canine | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001762 | ST002818 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Human | Homo sapiens | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001771 | ST002829 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Human | Homo sapiens | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001776 | ST002836 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Intestine) | Mammal | Mus musculus | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001776 | ST002837 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Blood) | Mammal | Mus musculus | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001809 | ST002909 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Human | Homo sapiens | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001883 | ST003222 | A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 | Mammal | Mus musculus | PC(16:0_22:6) [Data] |
| PR001890 | ST003038 | Untargeted lipidomics of WT and Cyp2c44(-/-) mice liver. | Mammal | Mus musculus | DG 30:4|DG 15:2_15:2 (806.57007@8.1) [Data] |
| PR001890 | ST003038 | Untargeted lipidomics of WT and Cyp2c44(-/-) mice liver. | Mammal | Mus musculus | PC 38:6 (806.56836@8.307) [Data] |
| PR001945 | ST003131 | Untargeted Metabolomics on mouse caecal contents | Mammal | Mus musculus | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001945 | ST003132 | Untargeted Metabolomics on Mouse colonic mucosa | Mammal | Mus musculus | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001977 | ST003178 | Post-Infectious MECFS at the NIH | Human | Homo sapiens | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) [Data] |
| PR001980 | ST003181 | Depression symptoms modifies differently plasma metabolites in pre- and post-menopausal women | Human | Homo sapiens | PC(38:6) / PDPC [Data] |
